These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 10945024

  • 1. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
    Gemma A, Uematsu K, Hagiwara K, Takenoshita S, Kudoh S.
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1253-9. PubMed ID: 10945024
    [Abstract] [Full Text] [Related]

  • 2. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
    Vincent F, Nagashima M, Takenoshita S, Khan MA, Gemma A, Hagiwara K, Bennett WP.
    Oncogene; 1997 Jul 03; 15(1):117-22. PubMed ID: 9233784
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 4. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
    Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE.
    Cancer Res; 1998 Dec 01; 58(23):5329-32. PubMed ID: 9850059
    [Abstract] [Full Text] [Related]

  • 5. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene.
    Lu SL, Kawabata M, Imamura T, Miyazono K, Yuasa Y.
    Biochem Biophys Res Commun; 1999 Jun 07; 259(2):385-90. PubMed ID: 10362519
    [Abstract] [Full Text] [Related]

  • 6. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.
    Cancer Res; 2000 Aug 15; 60(16):4507-12. PubMed ID: 10969799
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A, Davis BH, Sitrin MD, Brasitus TA, Bissonnette M.
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct 15; 283(4):G864-74. PubMed ID: 12223346
    [Abstract] [Full Text] [Related]

  • 8. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
    Yang HK, Kang SH, Kim YS, Won K, Bang YJ, Kim SJ.
    Oncogene; 1999 Apr 01; 18(13):2213-9. PubMed ID: 10327067
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer.
    Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, Lee HS, Kim NK, Kim SJ.
    Oncogene; 1999 Dec 02; 18(51):7280-6. PubMed ID: 10602482
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 11. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
    Kim WS, Park C, Hong SK, Park BK, Kim HS, Park K.
    Anticancer Res; 2000 May 15; 20(3A):1499-502. PubMed ID: 10928062
    [Abstract] [Full Text] [Related]

  • 12. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
    Ramp U, Jaquet K, Reinecke P, Nitsch T, Gabbert HE, Gerharz CD.
    Lab Invest; 1997 May 15; 76(5):739-49. PubMed ID: 9166292
    [Abstract] [Full Text] [Related]

  • 13. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C.
    Cancer Res; 1996 Jan 01; 56(1):44-8. PubMed ID: 8548772
    [Abstract] [Full Text] [Related]

  • 14. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
    Jiang W, Tillekeratne MP, Brattain MG, Banerji SS.
    Biochemistry; 1997 Dec 02; 36(48):14786-93. PubMed ID: 9402753
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
    Fink SP, Swinler SE, Lutterbaugh JD, Massagué J, Thiagalingam S, Kinzler KW, Vogelstein B, Willson JK, Markowitz S.
    Cancer Res; 2001 Jan 01; 61(1):256-60. PubMed ID: 11196171
    [Abstract] [Full Text] [Related]

  • 16. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E, Mori Y, Sato F, Yin J, Olaru A, Sterian A, Xu Y, Wang S, Schulmann K, Berki A, Kan T, Abraham JM, Meltzer SJ.
    Cancer Res; 2004 Nov 01; 64(21):7690-6. PubMed ID: 15520171
    [Abstract] [Full Text] [Related]

  • 17. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y, Zhong X, Uchida I, Koi M, Hemmi H.
    J Cell Physiol; 2001 Jun 01; 187(3):356-64. PubMed ID: 11319759
    [Abstract] [Full Text] [Related]

  • 18. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI.
    Crit Rev Oncog; 1999 Jun 01; 10(4):303-60. PubMed ID: 10654929
    [Abstract] [Full Text] [Related]

  • 19. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW.
    J Cell Physiol; 2003 Jan 01; 194(1):88-99. PubMed ID: 12447993
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.